Syngenis joins WA research heavyweights in RNA medicine push
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.